Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,721,227
  • Shares Outstanding, K 198,756
  • Annual Sales, $ 40 K
  • Annual Income, $ -21,820 K
  • 60-Month Beta 4.43
  • Price/Sales 46.87
  • Price/Cash Flow N/A
  • Price/Book 17.16
Trade OCGN with:

Options Overview Details

View History
  • Implied Volatility 182.74%
  • Historical Volatility 103.19%
  • IV Percentile 56%
  • IV Rank 31.32%
  • IV High 359.02% on 02/26/21
  • IV Low 102.36% on 07/29/21
  • Put/Call Vol Ratio 0.22
  • Today's Volume 166,248
  • Volume Avg (30-Day) 57,333
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 369,893
  • Open Int (30-Day) 270,240

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.04
  • Number of Estimates 3
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +42.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.72 +28.87%
on 10/05/21
10.60 -18.30%
on 10/14/21
+1.13 (+15.01%)
since 09/15/21
3-Month
6.32 +36.92%
on 07/16/21
10.60 -18.30%
on 10/14/21
+2.30 (+36.16%)
since 07/15/21
52-Week
0.25 +3,362.61%
on 11/02/20
18.77 -53.86%
on 02/08/21
+8.34 (+2,564.62%)
since 10/15/20

Most Recent Stories

More News
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and...

OCGN : 8.66 (-13.83%)
OCUGEN INVESTIGATION CONTINUED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Ocugen, Inc. - OCGN

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues to investigate Ocugen, Inc. (NasdaqCM: OCGN)....

OCGN : 8.66 (-13.83%)
4 Meme Stocks to Avoid Like the Plague in October

Meme stocks gained immense popularity earlier this year following the GameStop (GME) short squeeze due to social media hype. While the dizzying rallies caught the attention of retail traders, most meme...

BYND : 105.64 (-1.23%)
SDC : 5.54 (-3.32%)
RKLB : 12.80 (-5.67%)
OCGN : 8.66 (-13.83%)
Company News for Oct 6, 2021

Companies in The News Are: PEP, JNJ, OCGN, SPWR.

JNJ : 161.30 (+0.74%)
PEP : 158.81 (-0.28%)
SPWR : 27.54 (+0.18%)
OCGN : 8.66 (-13.83%)
Are Covid Stocks Back In Play? 3 To Watch If You Think They Are

The New Delta Variant Has Brought Coronavirus Into The Forefront Again. Is This Vaccine Stock 2.0?

NVAX : 161.95 (-4.59%)
IBB : 157.06 (-0.51%)
IBIO : 0.9000 (+2.79%)
APT : 6.30 (+0.48%)
SPY : 445.87 (+0.76%)
QQQ : 368.94 (+0.63%)
OCGN : 8.66 (-13.83%)
PFE : 41.49 (-0.43%)
MRNA : 324.21 (-2.31%)
AEMD : 3.43 (-3.65%)
BNTX : 247.68 (-1.06%)
GILD : 67.63 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 11.14
2nd Resistance Point 10.61
1st Resistance Point 9.63
Last Price 8.66
1st Support Level 8.12
2nd Support Level 7.59
3rd Support Level 6.61

See More

52-Week High 18.77
Fibonacci 61.8% 11.70
Fibonacci 50% 9.51
Last Price 8.66
Fibonacci 38.2% 7.32
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar